Phase 3 Readout~month
Phase 3 Topline: An Open-label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of L
- Company
- DBV Technologies S.A. (DBVT)
- Indication
- APDS
Other upcoming events for DBVT
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.